Pharmacosynthetics: Reimagining the pharmacogenetic approach

Brain Research

Volumn 1511, Issue , 2013, Pages 6-20

  Farrell, Martilias S ^a   Roth, Bryan L ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

DREADD; Pharmacogenetics; Pharmacosynthetics; RASSL; Synthetic biology

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2A RECEPTOR AGONIST; AMPHETAMINE; PHOSPHOPROTEIN DARPP 32; PSYCHOSTIMULANT AGENT;

BACTERIAL ARTIFICIAL CHROMOSOME; GENE CONTROL; GENE EXPRESSION SYSTEM; GENE INSERTION; GENE TRANSFER; HUMAN; NEUROMODULATION; NONHUMAN; PHARMACOGENETICS; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TRANSGENE;

ANIMALS; HUMANS; MODELS, BIOLOGICAL; NEURONS; PHARMACOGENETICS; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

RATTUS;

EID: 84879838237     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2012.09.043     Document Type: Review

References (60)

1. G.M. Alexander Remote control of neuronal activity in transgenic mice expressing evolved G protein-coupled receptors Neuron 63 2009 27 39
2. J.A. Allen, and B.L. Roth Strategies to discover unexpected targets for drugs active at G protein-coupled receptors Annu. Rev. Pharmacol. Toxicol. 51 2011 117 144
3. E. Alvarez-Curto Ligand regulation of the quaternary organization of cell surface M3 muscarinic acetylcholine receptors analyzed by fluorescence resonance energy transfer (FRET) imaging and homogeneous time-resolved FRET J. Biol. Chem. 285 2010 23318 23330
4. E. Alvarez-Curto Developing chemical genetic approaches to explore G protein-coupled receptor function: validation of the use of a receptor activated solely by synthetic ligand (RASSL) Mol. Pharmacol. 80 2011 1033 1046
5. B.N. Armbruster Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand Proc. Nat. Acad. Sci. U.S.A. 104 2007 5163 5168
6. J.M. Beaulieu, and R.R. Gainetdinov The physiology, signaling, and pharmacology of dopamine receptors Pharmacol. Rev. 63 2011 182 217
7. D. Centonze Dopaminergic control of synaptic plasticity in the dorsal striatum Eur. J. Neurosci. 13 2001 1071 1077
8. J. Cohen Developing prescriptions with a personal touch Science 275 1997 776
9. B.R. Conklin Engineering GPCR signaling pathways with RASSLs Nat. Methods 5 2008 673 678
10. S. de Silva, and W.J. Bowers Targeting the central nervous system with herpes simplex virus/ Sleeping Beauty hybrid amplicon vectors Curr. Gene. Ther. 11 2011 332 340
11. R.C. deCharms, and A. Zador Neural representation and the cortical code Annu. Rev. Neurosci. 23 2000 613 647
12. M. DeLong, and T. Wichmann Update on models of basal ganglia function and dysfunction Parkinsonism Relat. D. 15 3 2009 S237 S240
13. M.R. DeLong Primate models of movement disorders of basal ganglia origin Trends Neurosci. 13 1990 281 285
14. E.S. Deneris, and S.C. Wyler Serotonergic transcriptional networks and potential importance to mental health Nat. Neurosci. 15 2012 519 527
15. S. Dong, S.C. Rogan, and B.L. Roth Directed molecular evolution of DREADDs: a generic approach to creating next-generation RASSLs Nat. Protoc. 5 2010 561 573
16. Farrell, M.S.; Pei, Y.; Wan, Y.; Yadav, P.; Daigle, T.; Sciaky, N.; Simmons, A.; Nonneman, R.; Huang, X.P, Hufeisen, S.; Guettier, J.; Moy, S.S.; Wess, J.; Caron, M.G.; Calakos, N.; Roth, BL.; In revision. A Gαs DREADD mouse for selective modulation of cAMP production in striatopallidal neurons. Neuropsychopharmacology.
17. S.M. Ferguson Transient neuronal inhibition reveals opposing roles of indirect and direct pathways in sensitization Nat. Neurosci. 14 2011 22 24
18. S.M. Ferguson, and J.F. Neumaier Grateful DREADDs: engineered receptors reveal how neural circuits regulate behavior Neuropsychopharmacology 37 2012 296 297
19. K.D. Foust Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes Nat. Biotechnol. 27 2009 59 65
20. A.R. Garner Generation of a synthetic memory trace Science 335 2012 1513 1516
21. C.R. Gerfen D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons Science 250 1990 1429 1432
22. N. Gonzalez-Vacarezza Use of pharmacogenetics in bioequivalence studies to reduce sample size: an example with mirtazapine and CYP2D6 Pharmacogenomics J 2012
23. J.M. Guettier A chemical-genetic approach to study G protein regulation of beta cell function in vivo Proc. Nat. Acad. Sci. U.S.A. 106 2009 19197 19202
24. N. Heintz BAC to the future: the use of bac transgenic mice for neuroscience research Nat. Rev. Neurosci. 2 2001 861 870
25. J.M. Kim Light-driven activation of beta 2-adrenergic receptor signaling by a chimeric rhodopsin containing the beta 2-adrenergic receptor cytoplasmic loops Biochemistry 44 2005 2284 2292
26. T. Klabunde, and G. Hessler Drug design strategies for targeting G protein-coupled receptors Chembiochem. 3 2002 928 944
27. I.S. Kohane (Mis) treating the pharmacogenetic incidentalome Nat. Rev. Drug Discovery 11 2012 89 90
28. Y. Kozorovitskiy Recurrent network activity drives striatal synaptogenesis Nature 485 2012 646 650
29. M.J. Krashes Rapid, reversible activation of AgRP neurons drives feeding behavior in mice J. Clin. Invest. 121 2011 1424 1428
30. A.V. Kravitz Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry Nature 466 2010 622 626
31. B.N. LaDu Pharmacogenetics: defective enzymes in relation to reactions to drugs Annu. Rev. Med. 23 1972 453 468
32. M. Mallo Controlled gene activation and inactivation in the mouse Front. Biosci. 11 2006 313 327
33. S. Marion A beta-arrestin binding determinant common to the second intracellular loops of rhodopsin family G protein-coupled receptors J. Biol. Chem. 281 2006 2932 2938
34. G.M. McKenzie, and J.C. Szerb The effect of dihydroxyphenylalanine, pheniprazine and dextroamphetamine on the in vivo release of dopamine from the caudate nucleus J. Pharmacol. Exp. Ther. 162 1968 302 308
35. R. Narendran, and D. Martinez Cocaine abuse and sensitization of striatal dopamine transmission: a critical review of the preclinical and clinical imaging literature Synapse 62 2008 851 869
36. E. Oh Substitution of 5-HT1A receptor signaling by a light-activated G protein-coupled receptor J. Biol. Chem. 285 2010 30825 30836
37. C.C. Ouimet DARPP-32, a dopamine- and adenosine 3′:5′- monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization J. Neurosci. 4 1984 111 124
38. Y. Pei Engineered GPCRs as tools to modulate signal transduction Physiology (Bethesda) 23 2008 313 321
39. R.S. Ray Impaired respiratory and body temperature control upon acute serotonergic neuron inhibition Science 333 2011 637 642
40. S.C. Rogan, and B.L. Roth Remote control of neuronal signaling Pharmacol. Rev. 63 2011 291 315
41. E.T. Rolls, and A. Treves The neuronal encoding of information in the brain Prog. Neurobiol. 95 2011 448 490
42. B.L. Roth 5-hydroxytryptamine2 receptors coupled to phospholipase C in rat aorta: modulation of phosphoinositide turnover by phorbol ester J. Pharmacol. Exp. Ther. 238 1986 480 485
43. B.L. Roth, D.J. Sheffler, and W.K. Kroeze Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia Nat. Rev. Drug Discovery 3 2004 353 359
44. K. Sasaki Pharmacogenetic modulation of orexin neurons alters sleep/wakefulness states in mice PLoS One 6 2011 e20360
45. T. Shimazoe Roles of adenosine A(1) and A(2 A) receptors in the expression and development of methamphetamine-induced sensitization Eur. J. Pharmacol. 388 2000 249 254
46. J.D. Steketee, and P.W. Kalivas Drug wanting: behavioral sensitization and relapse to drug-seeking behavior Pharmacol. Rev. 63 2011 348 365
47. B.R. Stockwell Chemical genetics: ligand-based discovery of gene function Nat. Rev. Genet. 1 2000 116 125
48. D. Sulzer How addictive drugs disrupt presynaptic dopamine neurotransmission Neuron 69 2011 628 649
49. D.J. Surmeier D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons Trends Neurosci. 30 2007 228 235
50. P. Svenningsson Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons Neuroscience 84 1998 223 228
51. P. Svenningsson DARPP-32: an integrator of neurotransmission Annu. Rev. Pharmacol. Toxicol. 44 2004 269 296
52. A.G. Teschemacher Targeting specific neuronal populations using adeno- and lentiviral vectors: applications for imaging and studies of cell function Exp. Physiol. 90 2005 61 69
53. J.Z. Tsien Subregion- and cell type-restricted gene knockout in mouse brain Cell 87 1996 1317 1326
54. J.D. Urban Functional selectivity and classical concepts of quantitative pharmacology J. Pharmacol. Exp. Ther. 320 2007 1 13
55. Vardy, E.; Roth, B.L.; unpublished.
56. M.S. Weinberg, R.J. Samulski, and T.J. McCown Adeno-associated virus (AAV) gene therapy for neurological disease Neuropharmacology 2012
57. R.M. Weinshilboum, D.M. Otterness, and C.L. Szumlanski Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase Annu. Rev. Pharmacol. Toxicol. 39 1999 19 52
58. A.E. West, E.C. Griffith, and M.E. Greenberg Regulation of transcription factors by neuronal activity Nat. Rev. Neurosci. 3 2002 921 931
59. Z. Wu, A. Asokan, and R.J. Samulski Adeno-associated virus serotypes: vector toolkit for human gene therapy Mol. Ther. 14 2006 316 327
60. H. Yagi A synthetic biology approach reveals a CXCR4-G13-Rho signaling axis driving transendothelial migration of metastatic breast cancer cells Sci. Signal. 4 2011 ra60